Avi Weisfogel Conquers Sleep Disorders with Dental Expertise

To the working individual, getting enough sleep may become a secondary thought compared to other daily responsibilities. However, getting in those sleep hours is arguably one of the most important things related to personal health. Various disorders that deprive the individual of proper rest only complicated this issues further. Dr. Avi Weisfogel has recognized the common problem of sleep disorders and how they can be related to dental health. Weisfogel’s Dental Sleep Masters program looks to address this problem head-on.

The goal of Dental Sleep Masters is to reach other professionals in the dentistry practice through lectures and publications that speak on the relationship between dental care and restful sleep. Avi Weisfogel uses the program to teach specific treatments for sleep apnea and other disorders by creating a personalized plan for patients. Dental Sleep Masters and Weisfogel currently offer treatments that help hundreds of patients every month.

Avi Weisfogel has years of experience as an accomplished dentist, but his knack for being an entrepreneur and his management skills have helped to expand the reach of Dental Sleep Masters to a global presence. Weisfogel’s exceptional abilities have created a new solution for those who are not getting the sleep they need.

Prior to his creation of Dental Sleep Masters, Dr. Avi Weisfogel attended Rutgers University where he earned his Bachelor’s degree in psychology and biology. After graduation, Weisfogel enrolled at the College of Dentistry at New York University. He received his Doctor of Dental Surgery degree and proceeded to establish his own practice in New Jersey. Avi Weisfogel was a well-known and respected dentist for over a decade, during which time he studied sleep disorders and decided to transition to a more specialized field.

Weisfogel’s first official venture into sleep disorder treatment was the creation of Healthy Heart Sleep in 2010. The company assisted medical professionals across the globe in starting and managing laboratories that focus on studying ailments that occur during sleep. Avi Weisfogel incorporated dental care option

s into the process upon the founding of Owner Unlimited Sleep Patient, which specifically distributed information to other dentists on how to help patients suffering from sleep disorders.

Learn more about Avi Weisfogel here!

JeanMarie Guenot Extraordinary Business Woman and Scientist

 

LinkedIn makes it clear that JeanMarie Guenot has over 20 years’ experience in the biotechnology and pharmaceutical industry. Her history has her working in public and private companies, in pharmaceutical R&D, she has a vast amount of experience in commercial development, project and alliance management, business development and venture capital.

 

She was a business advisor in Basel, Switzerland and Shanghai, China for Hoffmann-La Roche from 2008 to 2009, Before this she served as the Vice President of Corporate and Business Development for PDL’s BioPharma. In this position, she led mergers and acquisitions, licensing, and alliance management for PDL’s R&D and in commercial product portfolios.

 

Dr. Guenot negotiated an $800 million 50:50 co-development and commercialization collaboration that involved three 2 Phase autoimmune and cancer disease drug candidates. This transaction also included a $100 million equity investment in PDL. In 2005 she received the BioBusiness Network’s innovative Bio-Partnering Award, and in 2006 was awarded the Deal of Distinction from the Licensing Executives Society.

 

JeanMarie Guenot started her career managing venture capital investments at Atlas Venture.  When she started her scientific career, it was as a principal scientist in preclinical R&D at Hoffman-La Roche where she developed drugs for metabolic diseases, autoimmune diseases, inflammation, and oncology. Her training is in physical and medicinal chemistry, focusing on quantum mechanical and methods for molecular dynamics, X-ray and NMR refinement and drug design.

 

Dr. Gueout graduated from the University of California, San Francisco where she received her Ph.D. and her MBA from the University of Pennsylvania, The Wharton School.  All of which is covered on her website JeanmarieGuenot.com.

 

She is at present the President of Amphivena Therapeutics, where they are working to find treatment and therapies for hematological conditions and malignancies. Amphivena Therapeutics, Inc. is a developer of cancer immunotherapeutics. Under an agreement with Janssen Biotech they have selected a clinical candidate against a tumor antigen and will further development in hematologic malignancies.

 

JeanMarie Guenot’s experience has made her into a dynamic business woman who has a well-disciplined mind and can and does apply all that she has learned to help ease suffering and try to make the world a better place for everyone to live in.  Jeanmarie has just negotiated a major partnership with Takeda, which you can read about on their website: https://www.takeda.com/news/2017/20170111_7659.html